Update on the optimal use of bortezomib in the treatment of multiple myeloma

Overview of attention for article published in Cancer Management and Research, March 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 51 publications that cite this research output.

51

The most recent citing publications are shown below. View all 51 publications that cite this research output on Dimensions.

Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance

Article in European Journal of Medicinal Chemistry (April 2024)

Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma

Article in Pharmaceutics (November 2023)

Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone

Article in Chronic Diseases and Translational Medicine (October 2023)